Skip to Content

Clinical Trials Detail

RTOG 0937 - A Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extra-Cranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED-SCLC)

Objective
The purpose of this study is to treat patients who have small cell lung cancer that did not completely respond to chemotherapy. The study will compare the effects, good and/or bad, of radiation given to the brain with radiation to the brain, chest and up to 4 other sites to find out which is better. This is a randomized study that will be compiled of 2 groups of participants; Arm 1 and Arm 2.
IRB Protocol Number
10-0876
Principal Investigator(s)
LAURIE GASPAR

Cancer Trials

  • Lung Cancer
Sponsor(s)
RTOG
Contact
ROBYN SWING at 720-848-0607
or ROBYN.SWING@UCDENVER.EDU
Eligibility and Other Participant Information
What To Expect : An screening period will occur to determine your eligibility to participate in the study. You will receive radiation to the brain OR radiation to the brain, chest, and other sites of cancer that did not completely respond to the chemotherapy in 2-5 weeks. You will be seen in follow-up visits at 2 weeks, 1 month, and 2 months after treatment; at 6, 9, and 12 months from the start of treatment; every 6 months for the next 2 years; and then yearly for your lifetime. // Eligibility criteria include but are not limited to: participants that are 18 years of age and older with extensive disease small cell lung cancer.